{
    "clinical_study": {
        "@rank": "129529", 
        "arm_group": [
            {
                "arm_group_label": "Laparoscop Anatomical  Hepatectomy", 
                "arm_group_type": "Experimental", 
                "description": "Total laparoscopic anatomical hepatectomy were performed, combined with cholecystectomy  when necessary. The intraoperative ultrasound,  hepatic segmental staining were used selectively."
            }, 
            {
                "arm_group_label": "Laparoscope Aon-anatomical Hepatectomy", 
                "arm_group_type": "Active Comparator", 
                "description": "Total laparoscopic aon-anatomical hepatectomy were performed, combined with cholecystectomy when necessary. The intraoperative ultrasound or hepatic segmental staining will be used to ensure the tumour was completely resected."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare short-term and long-term efficacy of two surgical\n      methods by laparoscopic hepatectomy, and provide the evidence for the choice of surgical\n      method from the pathology and cytology."
        }, 
        "brief_title": "Laparoscope Anatomical and Aon-anatomical Hepatectomy", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "Background:Hepatocellular carcinoma is the world's most common and most malignant tumor,\n      accounting for more than 90% of primary liver cancer, the incidence  ranked fifth of\n      malignant tumors in the world. surgery and comprehensive treatment is recognized by the\n      medical profession Surgical approach, including the open HCC hepatectomy and laparoscopic\n      hepatectomy, minimally invasive surgery is the main theme of the 21st century, and\n      laparoscopy as the one of the elements in the field of minimally invasive surgery which\n      carried out more and more in liver surgery, but which one of the two  methods to choice to\n      hepatectomy lack of sufficient scientific evidence.The RCT research of laparoscopic\n      anatomical and non-anatomical hepatectomy for HCC has not been reported at home and abroad;\n      Intervention:We let the 110 patients divide into A, B groups randomly who are meet the\n      inclusion criteria .Group A is Laparoscopic Anatomical Hepatectomy: Anatomy the\n      corresponding liver segment pedicle and hepatectomy along the Glisson fiber sheath.Group B\n      is Laparoscopic Aon-anatomical Hepatectomy:1 to 2 cm along the edge of the tumor complete\n      hepatectomy\n\n      Results:\n\n        1. operation time, intraoperative blood loss, rate of blood transfusion, complications and\n           mortality, postoperative liver function, resection margin, number of micrometastases\n           ,long-term curative effect and survival time were collected and analysed.\n\n        2. groups t-test \uff0cunivariate/multivariate analysis, logistic regression analysis, mixed\n           linear regression, Cox survival analysis \uff0cKaplan-Meier survival analysis\uff0cLog-rank\n           survival curves were used."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  (1) both male and female, aged 18 to 70; (2) Hepatocellular carcinoma(HCC)diagnosis\n             is clear preoperative; (3) preoperative liver function evaluation: Child-Pugh => B;\n             (4) the lesions can be anatomical  hepatectomy,( Indocyanine Green retention rate of\n             15 minutes) ICGR-15< 20%, the remaining liver volume is sufficient; (5) hepatic\n             single  lesions and tumor size between 3-10 cm, does not Invasion the main vein,\n             hepatic artery and vein and major inferior vena cava, did not occur extrahepatic\n             metastasis, and laparoscopic can complete resection; (6) surgery, radiofrequency\n             ablation (RFA), TACE treatment, radiotherapy and chemotherapy have not been\n             implemented (7) voluntary participation in the study, and informed consent.\n\n        Exclusion Criteria:\n\n          -  \u2022 (1) age <18 years or> 70 years , pregnant or lactating women; (2) HCC diagnosis is\n             not clear; (3) preoperative liver function evaluation:  Child-Pugh C grade; (4)\n             ICGR-15> 20%, the remaining liver volume is insufficient (account for standard liver\n             volume <35%); (5) preoperative tumor has ruptured, or has been undergoing surgery,\n             radiofrequency ablation (RFA),  transhepatic arterial chemotherapy and\n             embolization(TACE) or radiotherapy and chemotherapy treatment; (6) preoperative\n             examinations showed multiple (>3)liver lesion or tumor diameter <3 or> 10 cm, a\n             clearly major portal vein, hepatic vein, inferior vena vein tumor thrombus; (7)\n             extrahepatic metastasis; (8) cardio-pulmonary function and other diseases can not\n             tolerate surgery; (9) the patient refused to sign the informed consent form; (10) the\n             tumor has spread and / or lymph node metastasis intraoperative found ; (11)\n             intraoperative found not to be the HCC, such as metastatic hepatic carcinoma, hilar\n             cell carcinoma; (12) Histological examinations showed it is cholangio carcinoma, or\n             mixed liver carcinoma; (13) foreign and Hong Kong, Macao, Taiwan or other areas,\n             estimated that difficult to track, follow-up postoperative"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009176", 
            "org_study_id": "SWHZSG003", 
            "secondary_id": "Zhengshuguo"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laparoscop Anatomical  Hepatectomy", 
                "description": "We let the 110 patients divide into A, B groups randomly who are meet the inclusion criteria .Group A is Laparoscopic Anatomical Hepatectomy: Anatomy the corresponding liver segment pedicle and hepatectomy along the Glisson fiber sheath", 
                "intervention_name": "Laparoscopic Anatomical Hepatectomy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Laparoscope Aon-anatomical Hepatectomy", 
                "description": "We let the 110 patients divide into A, B groups randomly who are meet the inclusion criteria .Group B is Laparoscopic Aon-anatomical Hepatectomy:1 to 2 cm along the edge of the tumor complete hepatectomy", 
                "intervention_name": "Laparoscopic Aon-anatomical Hepatectomy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hepatocellular Carcinoma", 
            "Laparoscopic", 
            "Aon-anatomical hepatectomy", 
            "Anatomical hepatectomy", 
            "Micrometastases"
        ], 
        "lastchanged_date": "December 8, 2013", 
        "location": {
            "contact": {
                "email": "shuguozh@gmail.com", 
                "last_name": "Shuguo Zheng, Professor", 
                "phone": "0086-13508308676"
            }, 
            "facility": {
                "address": {
                    "city": "Chongqing", 
                    "country": "China", 
                    "state": "Chongqing", 
                    "zip": "400038"
                }, 
                "name": "Southwest Hospital"
            }, 
            "investigator": {
                "last_name": "shuguo Zheng, professer", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Prospective, Randomized Case-control(RCT) Research of Laparoscope Anatomical and Aon-anatomical Hepatectomy Treat HCC", 
        "overall_contact": {
            "email": "shuguozh@gmail.com", 
            "last_name": "Shuguo Zheng", 
            "phone": "0086-13508308676"
        }, 
        "overall_official": {
            "affiliation": "Shuguo Zheng, MD Study Director Institute of Hepatobiliary Surgery ,Southwest Hospital ,Third Military Medical University", 
            "last_name": "Shuguo Zheng", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "follow-up after the surgery every 2 months, to understand relapse, death, statistics 1 year, 3-year and 5-year survival, disease-free survival, recurrence rate.", 
            "measure": "Survival rate", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "reference": [
            {
                "PMID": "15508102", 
                "citation": "Bosch FX, Ribes J, D\u00edaz M, Cl\u00e9ries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16. Review."
            }, 
            {
                "PMID": "18019727", 
                "citation": "Kaido T. Recent randomized controlled trials in hepatectomy. Hepatogastroenterology. 2007 Sep;54(78):1825-30. Review."
            }, 
            {
                "PMID": "9409569", 
                "citation": "Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997 Dec;226(6):704-11; discussion 711-3."
            }, 
            {
                "PMID": "15798459", 
                "citation": "Figueras J, Llado L, Ruiz D, Ramos E, Busquets J, Rafecas A, Torras J, Fabregat J. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg. 2005 Apr;241(4):582-90."
            }, 
            {
                "PMID": "18836806", 
                "citation": "Kobayashi A, Miyagawa S, Miwa S, Nakata T. Prognostic impact of anatomical resection on early and late intrahepatic recurrence in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2008;15(5):515-21. doi: 10.1007/s00534-007-1293-7. Epub 2008 Oct 4."
            }, 
            {
                "PMID": "16041216", 
                "citation": "Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005 Aug;242(2):252-9."
            }, 
            {
                "PMID": "11420484", 
                "citation": "Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001 Jul;234(1):63-70."
            }, 
            {
                "PMID": "14607620", 
                "citation": "Zhou XD. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):35-41. Review."
            }, 
            {
                "PMID": "15816471", 
                "citation": "Hanazaki K, Kajikawa S, Shimozawa N, Matsushita A, Machida T, Shimada K, Yazawa K, Koide N, Adachi W, Amano J. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology. 2005 Mar-Apr;52(62):524-9."
            }, 
            {
                "PMID": "18044786", 
                "citation": "Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, Lee TK, Poon RT, Fan ST. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transpl. 2007 Dec;13(12):1669-77."
            }, 
            {
                "PMID": "18520234", 
                "citation": "Man K, Lo CM, Xiao JW, Ng KT, Sun BS, Ng IO, Cheng Q, Sun CK, Fan ST. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg. 2008 Jun;247(6):1049-57. doi: 10.1097/SLA.0b013e31816ffab6XXX."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009176"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Southwest Hospital, China", 
            "investigator_full_name": "Shuguo Zheng, MD", 
            "investigator_title": "Professor of Hepatobiliary Surgery Institute; Chief Physician; Administrator of laparoscopic department", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "hepatic failure,hemorrhage,biliary leakage,ascites,intra-abdominal infection,pleural effusion,pulmonary infection,cardiac insufficiency.", 
            "measure": "postoperative complications", 
            "safety_issue": "Yes", 
            "time_frame": "Duration hospitalization(an expected average of 7 days)"
        }, 
        "source": "Southwest Hospital, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shuguo Zheng, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}